Insider Transactions for Vanda Pharmaceuticals Inc. (VNDA)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 04, 2024Sale$4.418,14735,917205,766Mar 06, 2024, 04:50 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 05, 2024Sale$4.188,94137,396196,825Mar 06, 2024, 04:50 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 04, 2024Sale$4.417,49833,091139,018Mar 06, 2024, 04:48 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 05, 2024Sale$4.219,22938,830129,789Mar 06, 2024, 04:48 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 05, 2024Sale$4.1324,288100,2731,871,730Mar 06, 2024, 04:47 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 04, 2024Sale$4.2430,884131,0661,896,018Mar 06, 2024, 04:47 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 04, 2024Sale$4.485,79825,982239,916Mar 06, 2024, 04:46 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 05, 2024Sale$4.208,90237,411231,014Mar 06, 2024, 04:46 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 04, 2024Sale$4.308,72737,495322,253Mar 06, 2024, 04:46 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 05, 2024Sale$4.138,68435,884313,569Mar 06, 2024, 04:46 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerAug 21, 2023Sale$5.843,72421,748113,816Aug 23, 2023, 04:23 PM
VNDAVanda Pharmaceuticals Inc.Mitchell Stephen RayDirectorAug 10, 2023Sale$6.056,50039,34929,328Aug 11, 2023, 04:36 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerJul 28, 2023Sale$6.302,21213,945122,514Aug 01, 2023, 04:30 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerJun 15, 2023Sale$6.2916,000100,710122,926Jun 20, 2023, 04:34 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselJun 13, 2023Sale$6.5614,60095,75488,913Jun 15, 2023, 04:20 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 02, 2023Sale$6.248,43752,685111,814Mar 06, 2023, 06:26 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 03, 2023Sale$6.258,30151,887103,513Mar 06, 2023, 06:26 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 02, 2023Sale$6.237,72048,123121,653Mar 06, 2023, 06:26 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 03, 2023Sale$6.324,11325,994117,540Mar 06, 2023, 06:26 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 03, 2023Sale$6.2522,538140,8761,476,902Mar 06, 2023, 06:25 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 02, 2023Sale$6.2322,426139,7181,499,440Mar 06, 2023, 06:25 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 02, 2023Sale$6.267,96649,846144,894Mar 06, 2023, 06:25 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 03, 2023Sale$6.285,96837,499138,926Mar 06, 2023, 06:25 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 02, 2023Sale$6.208,50952,793214,248Mar 06, 2023, 06:24 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 03, 2023Sale$6.268,26851,791205,980Mar 06, 2023, 06:24 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselDec 15, 2022Sale$7.018,00056,07087,551Dec 16, 2022, 04:38 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 06, 2022Option Exercise$6.04123,615747,2211,455,116Dec 07, 2022, 05:58 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 05, 2022Sale$6.04122,285739,0611,427,401Dec 07, 2022, 05:58 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerDec 06, 2022Option Exercise$6.0412,29274,227124,952Dec 07, 2022, 05:56 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentAug 26, 2022Option Exercise$3.121,2503,900190,057Aug 29, 2022, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerAug 22, 2022Sale$10.273,60537,00796,673Aug 23, 2022, 05:01 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselAug 15, 2022Sale$10.308,30085,504100,162Aug 17, 2022, 04:06 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerJul 28, 2022Sale$10.972,23924,562117,452Aug 01, 2022, 04:45 PM
VNDAVanda Pharmaceuticals Inc.Mitchell Stephen RayDirectorJun 13, 2022Sale$9.482,70025,5936,515Jun 14, 2022, 08:37 PM
VNDAVanda Pharmaceuticals Inc.Watkins ThomasDirectorJun 02, 2022Sale$5.8821,441126,02969,505Jun 03, 2022, 04:31 PM
VNDAVanda Pharmaceuticals Inc.DUGAN RICHARD WDirectorMay 31, 2022Sale$5.8721,500126,30274,887Jun 02, 2022, 04:47 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 02, 2022Sale$11.0912,060133,779103,851Mar 02, 2022, 09:29 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 02, 2022Sale$11.196,97478,060100,278Mar 02, 2022, 09:28 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 02, 2022Sale$11.1529,588329,9451,352,766Mar 02, 2022, 09:27 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 01, 2022Sale$11.197,50884,0151,382,354Mar 02, 2022, 09:27 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 01, 2022Sale$11.193,47338,863128,523Mar 02, 2022, 09:27 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 02, 2022Sale$11.288,83299,650119,691Mar 02, 2022, 09:27 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 01, 2022Sale$11.194,08445,700200,324Mar 02, 2022, 09:26 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 02, 2022Sale$11.2711,517129,792188,807Mar 02, 2022, 09:26 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEONov 30, 2021Option Exercise$9.40128,3241,206,4961,299,386Dec 02, 2021, 04:31 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 01, 2021Option Exercise$9.24117,8761,089,1271,321,062Dec 02, 2021, 04:31 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerSep 15, 2021Option Exercise$14.4628,943418,64498,804Sep 17, 2021, 08:52 AM
VNDAVanda Pharmaceuticals Inc.Mitchell Stephen RayDirectorSep 09, 2021Sale$14.3938,218549,91328,324Sep 13, 2021, 04:40 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerAug 20, 2021Sale$15.393,65056,19074,552Aug 23, 2021, 04:36 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselAug 16, 2021Sale$16.153,71559,98983,211Aug 17, 2021, 04:31 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerJul 28, 2021Sale$19.242,13040,97399,296Jul 30, 2021, 09:15 AM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerJul 26, 2021Sale$19.697,250142,77686,685Jul 27, 2021, 04:37 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerMar 15, 2021Option Exercise$14.8133,000488,810111,935Mar 16, 2021, 04:20 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 08, 2021Sale$18.00175,0003,150,0521,221,062Mar 09, 2021, 05:15 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 05, 2021Sale$17.855,60099,96692,326Mar 08, 2021, 05:47 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 01, 2021Sale$18.6011,856220,543100,200Mar 03, 2021, 06:43 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 02, 2021Sale$18.547,674142,30792,526Mar 03, 2021, 06:43 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerMar 02, 2021Sale$18.453,88871,72978,202Mar 03, 2021, 06:42 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 01, 2021Sale$18.457,479138,0031,411,268Mar 03, 2021, 06:41 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 02, 2021Sale$18.3415,206278,9021,396,062Mar 03, 2021, 06:41 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 01, 2021Sale$18.573,32761,780107,470Mar 03, 2021, 06:40 PM
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO & TreasurerMar 02, 2021Sale$18.236,044110,191101,426Mar 03, 2021, 06:40 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerMar 02, 2021Sale$18.043,86569,71796,935Mar 03, 2021, 06:40 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 01, 2021Sale$18.663,84571,744188,328Mar 03, 2021, 06:39 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 02, 2021Sale$18.1916,620302,273171,708Mar 03, 2021, 06:39 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerFeb 24, 2021Option Exercise$16.1845,485736,095123,786Feb 26, 2021, 05:17 PM
VNDAVanda Pharmaceuticals Inc.Watkins ThomasDirectorFeb 16, 2021Sale$10.3020,818214,50655,323Feb 18, 2021, 08:43 PM
VNDAVanda Pharmaceuticals Inc.DUGAN RICHARD WDirectorFeb 16, 2021Sale$10.2820,754213,31360,641Feb 18, 2021, 08:43 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 14, 2020Sale$10.76112,5691,211,6061,347,283Dec 15, 2020, 04:24 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 15, 2020Sale$10.6985,813917,1461,342,897Dec 15, 2020, 04:24 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 11, 2020Sale$10.6376,870817,2591,320,816Dec 15, 2020, 04:24 PM
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, Chief Marketing OfficerAug 20, 2020Sale$11.083,71041,10956,290Aug 21, 2020, 06:08 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselAug 14, 2020Sale$11.813,68443,52679,356Aug 17, 2020, 04:42 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerAug 12, 2020Sale$11.817,20085,01875,487Aug 14, 2020, 04:39 PM
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerJul 27, 2020Sale$10.627,31377,63182,687Jul 29, 2020, 08:17 PM
VNDAVanda Pharmaceuticals Inc.Watkins ThomasDirectorMay 29, 2020Sale$9.0024,677221,98645,000Jun 02, 2020, 04:13 PM
VNDAVanda Pharmaceuticals Inc.DUGAN RICHARD WDirectorMay 28, 2020Sale$8.8525,129222,50650,770May 29, 2020, 04:10 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 02, 2020Sale$10.303,14832,43684,277Mar 04, 2020, 05:03 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselMar 03, 2020Sale$10.511,23713,00483,040Mar 04, 2020, 05:03 PM
VNDAVanda Pharmaceuticals Inc.Reverberi Gian PieroSVP & Chief Commercial OfficerMar 02, 2020Sale$10.181,45014,755165,384Mar 04, 2020, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 02, 2020Sale$10.5710,428110,2111,284,151Mar 04, 2020, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 03, 2020Sale$10.985,15256,5441,278,999Mar 04, 2020, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Kelly James PatrickEVP & Chief Financial OfficerMar 02, 2020Sale$10.1912,968132,087192,758Mar 04, 2020, 05:01 PM
VNDAVanda Pharmaceuticals Inc.Kelly James PatrickEVP & Chief Financial OfficerMar 03, 2020Sale$10.765,88963,359186,869Mar 04, 2020, 05:01 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 02, 2020Sale$10.0412,223122,686165,008Mar 04, 2020, 05:00 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentMar 03, 2020Sale$10.665,53558,984159,473Mar 04, 2020, 05:00 PM
VNDAVanda Pharmaceuticals Inc.Reverberi Gian PieroSVP & Chief Commercial OfficerJan 02, 2020Sale$16.061,15518,551166,834Jan 06, 2020, 05:26 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOJan 02, 2020Sale$16.009,467151,4931,234,579Jan 06, 2020, 05:26 PM
VNDAVanda Pharmaceuticals Inc.Kelly James PatrickEVP & Chief Financial OfficerJan 02, 2020Sale$15.944,02064,086205,726Jan 06, 2020, 05:25 PM
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentJan 02, 2020Sale$15.934,02064,021147,231Jan 06, 2020, 05:25 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 11, 2019Sale$13.46161,5722,174,3471,300,654Dec 13, 2019, 04:21 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEODec 12, 2019Sale$13.50155,8372,103,1321,314,082Dec 13, 2019, 04:21 PM
VNDAVanda Pharmaceuticals Inc.DUGAN RICHARD WDirectorAug 26, 2019Option Exercise$14.8230,000444,45050,770Aug 28, 2019, 04:30 PM
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP & General CounselAug 14, 2019Sale$14.692,57537,82957,425Aug 15, 2019, 04:58 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMay 20, 2019Sale$13.78141,0261,942,8641,272,726May 21, 2019, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMay 21, 2019Sale$13.89151,8912,109,6401,284,327May 21, 2019, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMay 17, 2019Sale$13.88174,5982,423,7221,276,343May 21, 2019, 05:02 PM
VNDAVanda Pharmaceuticals Inc.Reverberi Gian PieroSVP & Chief Commercial OfficerMar 01, 2019Sale$20.174388,832168,432Mar 04, 2019, 05:12 PM
VNDAVanda Pharmaceuticals Inc.Reverberi Gian PieroSVP & Chief Commercial OfficerMar 04, 2019Sale$19.924438,823167,989Mar 04, 2019, 05:12 PM
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPresident and CEOMar 04, 2019Sale$19.4138,166740,8021,178,970Mar 04, 2019, 05:10 PM